Glaxo Smithkline Pharmaceuticals

GSK (GlaxoSmithKline) is a global biopharma company headquartered in London, United Kingdom. With a legacy spanning over a century, GSK is dedicated to uniting science, technology, and talent to get ahead of disease and improve health outcomes worldwide. The company focuses on four key therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory.

GSK is known for its strong research and development capabilities, which have resulted in groundbreaking vaccines and medicines. Its vaccine portfolio is one of the broadest globally, including vaccines for influenza, shingles, meningitis, and more. In pharmaceuticals, GSK develops innovative treatments for chronic diseases, cancer, and viral infections, particularly through its leading HIV-focused division, ViiV Healthcare.

The company has a presence in more than 100 countries and operates numerous manufacturing and R&D facilities worldwide. GSK is committed to using science to positively impact global health while maintaining high ethical and sustainability standards.

With a purpose-driven approach, GSK aims to prevent and treat disease more effectively and make healthcare accessible. Its bold ambition is to positively impact the health of 2.5 billion people over the next decade through innovation, partnerships, and a patient-first mindset, reinforcing its position as a trusted name in global healthcare.